Colgate-Palmolive (CL)
Makes Colgate oral care, Palmolive household products and Hill's specialty pet nutrition.
$87.06
After hours+0.02 (+0.02%)
At close$87.05(+0.91%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,915 | 4,950 | 5,065 | 5,058 | 5,033 | 4,944 | 4,911 | 5,110 | 5,131 | 5,230 | 5,324 | 5,361 |
| Cost of revenue | 2,032 | 2,007 | 2,029 | 1,989 | 1,959 | 1,961 | 1,924 | 2,041 | 2,082 | 2,084 | 2,098 | 2,065 |
| Gross profit | 2,883 | 2,943 | 3,036 | 3,069 | 3,074 | 2,983 | 2,987 | 3,069 | 3,049 | 3,146 | 3,226 | 3,296 |
| 1,820 | 1,803 | 1,859 | 1,911 | 1,964 | 1,893 | 1,911 | 1,989 | 1,952 | 2,069 | 2,076 | 2,280 | |
| Research & development | 0 | 343 | 0 | 0 | 0 | 355 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1,820 | 1,803 | 1,937 | 1,959 | 1,999 | 1,893 | 1,898 | 1,986 | 1,992 | 2,069 | 2,070 | 2,130 | |
| Selling & marketing | 0 | 0 | 672 | 706 | 694 | 0 | 0 | 678 | 674 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 1,265 | 1,253 | 1,305 | 0 | 0 | 1,308 | 1,318 | 0 | 0 | 0 |
| Other expenses | 0 | −343 | −78 | −48 | −35 | −355 | 13 | 3 | −40 | 0 | 6 | 150 |
| Operating income | 1,063 | 1,140 | 1,177 | 1,158 | 1,110 | 1,090 | 1,076 | 1,080 | 1,097 | 1,077 | 1,156 | 1,016 |
| −107 | −152 | −210 | −148 | −124 | −96 | −123 | −73 | −105 | −970 | −264 | −66 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 16 | 15 | 21 | 21 | 18 | 16 | 17 |
| Interest expense | 60 | 62 | 58 | 62 | 56 | 66 | 66 | 71 | 67 | 64 | 62 | 62 |
| Other non-operating income | 47 | 90 | 152 | 86 | 68 | 30 | 57 | 14 | 38 | 906 | 202 | 4 |
| Income before tax | 956 | 988 | 967 | 1,010 | 986 | 994 | 953 | 1,007 | 992 | 107 | 892 | 950 |
| Income tax expense | 209 | 228 | 238 | 243 | 210 | 214 | 227 | 234 | 226 | 112 | 211 | 231 |
| Net income from continuing operations | 747 | 760 | 729 | 767 | 776 | 779 | 726 | 773 | 766 | −5 | 681 | 719 |
| Net income | 708 | 718 | 683 | 731 | 737 | 739 | 690 | 743 | 735 | −37 | 646 | 693 |
| EPS, basic | $0.86 | $0.87 | $0.83 | $0.89 | $0.90 | $0.91 | $0.85 | $0.92 | $0.91 | −$0.05 | $0.81 | $0.87 |
| EPS, diluted | $0.86 | $0.87 | $0.83 | $0.89 | $0.90 | $0.90 | $0.85 | $0.91 | $0.91 | −$0.05 | $0.80 | $0.86 |
| Weighted average shares, basic | 826 | 823 | 823 | 820 | 818 | 818 | 818 | 808 | 808 | 805 | 802 | 797 |
| Weighted average shares, diluted | 827 | 825 | 826 | 824 | 823 | 823 | 823 | 816 | 810 | 805 | 805 | 806 |
| EBITDA | 1,160 | 1,200 | 1,175 | 1,229 | 1,192 | 1,208 | 1,167 | 1,217 | 1,217 | 344 | 1,110 | 1,167 |
| Depreciation & amortization | 144 | 150 | 150 | 157 | 150 | 148 | 148 | 151 | 158 | 173 | 156 | 155 |
| EBIT | 1,016 | 1,050 | 1,025 | 1,072 | 1,042 | 1,060 | 1,019 | 1,066 | 1,059 | 171 | 954 | 1,012 |